Pharma Collaboration between India and China- API Import & Export

Time: 4:00pm ~ 6:00pm, 16 Dec. 2021 (UTC+8 China Time)

Introduction: The Indian pharmaceutical sector is enjoying a tremendous growth trajectory as the government seeks to improve healthcare access for its burgeoning population while also reducing supply chain dependency on other countries. In the meanwhile, Indian API has its own unique and irreplaceable advantages in the global supply chain, of which a large proportion is being exported every year. More and more Indian pharma enterprises are looking into the opportunity to expand business in China, and thus it’s crucial to understand the constantly updated policies and regulations, drug registration requirements and procedures, etc. in China and find local reliable and committed partners.

Language: English

Organizer: CPhI & P-MEC China

Partners: Pharmexcil, CCCMHPIE

Sponsor: China Chinopharma Ltd. (CSC)


Welcome Address

Mr. Uday Bhaskar 

Director General from PHARMEXCIL

 Global Opportunities for Indian and Chinese Manufacturers


Mr. Aurelio Arias | Engagement Manager from IQVIA

Imported API Registration and Dealing in China


Mr. Steven Yu | Director of International Trade Dept. from CSC


- Procedures and Precautions of Imported API Registration in China

- Standardization of API Import and Clearance in China

- Standardization of Dealing Pharmaceutical Products in China

Panel Discussion: Outlook and Opportunity of Pharma Collaboration between India and China

Moderator: Mr. Kyrie Huang from CCCMHPIE


Sponsor Introduction


Copyright 2006-2021 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182
Powered by